ACSL5
protein-codingacyl-CoA synthetase long chain family member 5, the group of Acyl-CoA synthetase family
Gene summary
The protein encoded by this gene is an isozyme of the long-chain fatty-acid-coenzyme A ligase family. Although differing in substrate specificity, subcellular localization, and tissue distribution, all isozymes of this family convert free long-chain fatty acids into fatty acyl-CoA esters, and thereby play a key role in lipid biosynthesis and fatty acid degradation. This isozyme is highly expressed in uterus and spleen, and in trace amounts in normal brain, but has markedly increased levels in malignant gliomas. This gene functions in mediating fatty acid-induced glioma cell growth. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
- FACL5
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~54.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: Unknown
Disease ID:MONDO:0957253
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0957253
Submitter: LiferaOmics
Genetic evidence – Published: PMID: 33191500 — One large consanguineous family with 6 affected individuals, all homozygous for NM_203379.2:c.1358C>A;p.(Thr453Lys); AR inheritance; segregation within pedigree; consistent neonatal-onset vomiting, chronic diarrhea, and FTT. Case-level points (single pedigree, shared variant) = 0.1; Functional data = 0.4; segregation = 1 PMID: 41572200 — One unrelated proband homozygous for NM_016234.4:c.1748G>A;p.(Gly583Asp); AR inheritance; consistent phenotype; no reported segregation. Case-level points = 0.1; segregation = 0; case-control = 0 Published genetic evidence total = 1.6 / 12 Genetic evidence – Current case: 1 proband with homozygous NM_016234.4:c.700+1del (canonical +1 splice donor, predicted null); neonatal vomiting, chronic diarrhea, FTT; positive consanguinity; no additional affected relatives; no segregation data; no case-control data. Case-level points (default for predicted null in AR disease) = 1.0 (AR predicted/proven null = 1.5, − 0.5 downgrade for homozygosity/consanguinity); segregation = 0; case-control = 0 Current case contribution = 1.0 / 12 Total genetic evidence (published + current) = 2.6/ 12 Experimental evidence – Published (PMID: 33191500): Functional alteration showing reduced ACSL5 enzymatic activity (Patient cells) = 1.5; biochemical function consistent with intestinal long-chain fatty acid metabolism = 0.5; intestinal expression reported = 0.5; Non-human model organism = 2.0 (PMID: 33106515) Experimental evidence total = 4.5 / 6 Overall score = 7.1 points
Inheritance Pattern: AR
Disease ID:MONDO:0957253
Submitter: PanelApp Australia
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ACSL5 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_203379.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 1 | 1 | 3 | ||
| missense | 1 | 81 | 6 | 2 | 90 | |
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 5 | 5 | ||||
| Total | 1 | 0 | 87 | 7 | 3 | 98 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_976313.1 | 20 | MANE Select | |
| Ensembl | ENSP00000346680.4 | 20 | MANE Select | |
| RefSeq | NP_001373966.1 | 20 | Standard | |
| RefSeq | NP_057318.2 | 21 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Adipocytokine signaling pathway - Homo sapiens (human)
- Peroxisome - Homo sapiens (human)
- Thermogenesis - Homo sapiens (human)
- Fatty acid degradation - Homo sapiens (human)
- Fatty acid biosynthesis - Homo sapiens (human)
Biological Process
- long-chain fatty acid metabolic process
- long-chain fatty-acyl-CoA biosynthetic process
Molecular Function
- long-chain fatty acid-CoA ligase activity
- ATP binding
- decanoate-CoA ligase activity
Cellular Component
- nucleus
- nucleolus
- mitochondrion
- mitochondrial outer membrane
- endoplasmic reticulum membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000356116
- Coding exons
- 21
- Length
- 54363
- Individuals with no LoFs
- 125703
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 45
- Defined
- 125748
- p
- 0.000179
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.717 | 369 | 410 | 0.900 | 0.0000212 | 4841 |
| Missense (PolyPhen) | 129 | 161.08 | 0.80082 | 1941 | ||
| Synonymous | 0.960 | 144 | 159 | 0.903 | 0.00000903 | 1411 |
| Loss of Function | 2.96 | 21 | 41.6 | 0.505 | 0.00000191 | 517 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00025 | 0.00025 | rare |
| Latino/Admixed American | 0.00026 | 0.00026 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00033 | 0.00033 | rare |
| Finnish | 0.00014 | 0.00014 | rare |
| European (Non-Finnish) | 0.00017 | 0.00017 | rare |
| South Asian | 0.00013 | 0.00013 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Acyl-CoA synthetases (ACSL) activate long-chain fatty acids for both synthesis of cellular lipids, and degradation via beta-oxidation. ACSL5 may activate fatty acids from exogenous sources for the synthesis of triacylglycerol destined for intracellular storage (By similarity). Utilizes a wide range of saturated fatty acids with a preference for C16-C18 unsaturated fatty acids (By similarity). It was suggested that it may also stimulate fatty acid oxidation (By similarity). At the villus tip of the crypt-villus axis of the small intestine may sensitize epithelial cells to apoptosis specifically triggered by the death ligand TRAIL. May have a role in the survival of glioma cells. {ECO:0000250, ECO:0000269|PubMed:17681178, ECO:0000269|PubMed:18806831, ECO:0000269|PubMed:19459852}.;
Recessive Scores
- pRec
- 0.157
Intolerance Scores
- LoFtool
- 0.837
- RVIS EVS
- 0.27
- RVIS percentile EVS
- 70.64
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.791
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |